title: Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen.
authors.affiliation: Department of Biochemistry, University Hospital, Montpellier 34295, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Badiou
authors.forename: Corinne Merle
authors.initials: CM
authors.lastname: De Boever
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Dupuy
authors.forename: Vincent
authors.initials: V
authors.lastname: Baillat
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Cristol
authors.forename: Jacques
authors.initials: J
authors.lastname: Reynes
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D001161:Arteriosclerosis / Q000139:chemically induced; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood*; D061466:Lopinavir; D011744:Pyrimidinones / Q000009:adverse effects*; D019438:Ritonavir / Q000009:adverse effects*
chemical_list: D017320:HIV Protease Inhibitors; D008055:Lipids; D008077:Lipoproteins, LDL; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir